Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)

Rami Musharrafieh, Jiantao Zhang, Peter Tuohy, Naoya Kitamura, Shreya Sai Bellampalli, Yanmei Hu, Rajesh Khanna, Jun Wang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Enterovirus D68 (EV-D68) is an atypical nonpolio enterovirus that mainly infects the respiratory system of humans, leading to moderate-to-severe respiratory diseases. In rare cases, EV-D68 can spread to the central nervous system and cause paralysis in infected patients, especially young children and immunocompromised individuals. There is currently no approved vaccine or antiviral available for the prevention and treatment of EV-D68. In this study, we aimed to improve the antiviral potency and selectivity of a previously reported EV-D68 inhibitor, dibucaine, through structure-activity relationship studies. In total, 60 compounds were synthesized and tested against EV-D68 using the viral cytopathic effect assay. Three compounds 10a, 12a, and 12c were identified to have significantly improved potency (EC 50 < 1 μM) and a high selectivity index (>180) compared with dibucaine against five different strains of EV-D68 viruses. These compounds also showed potent antiviral activity in neuronal cells, such as A172 and SH-SY5Y cells, suggesting they might be further developed for the treatment of both respiratory infection as well as neuronal infection.

Original languageEnglish (US)
JournalJournal of Medicinal Chemistry
DOIs
StatePublished - Jan 1 2019

Fingerprint

Enterovirus
Antiviral Agents
Dibucaine
Viral Cytopathogenic Effect
Structure-Activity Relationship
quinoline
Paralysis
Respiratory Tract Infections
Respiratory System
Vaccines
Central Nervous System
Viruses
Therapeutics
Infection

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68). / Musharrafieh, Rami; Zhang, Jiantao; Tuohy, Peter; Kitamura, Naoya; Bellampalli, Shreya Sai; Hu, Yanmei; Khanna, Rajesh; Wang, Jun.

In: Journal of Medicinal Chemistry, 01.01.2019.

Research output: Contribution to journalArticle

Musharrafieh, Rami ; Zhang, Jiantao ; Tuohy, Peter ; Kitamura, Naoya ; Bellampalli, Shreya Sai ; Hu, Yanmei ; Khanna, Rajesh ; Wang, Jun. / Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68). In: Journal of Medicinal Chemistry. 2019.
@article{81d1a4e5cf2245198a4c3c75e8a6767a,
title = "Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)",
abstract = "Enterovirus D68 (EV-D68) is an atypical nonpolio enterovirus that mainly infects the respiratory system of humans, leading to moderate-to-severe respiratory diseases. In rare cases, EV-D68 can spread to the central nervous system and cause paralysis in infected patients, especially young children and immunocompromised individuals. There is currently no approved vaccine or antiviral available for the prevention and treatment of EV-D68. In this study, we aimed to improve the antiviral potency and selectivity of a previously reported EV-D68 inhibitor, dibucaine, through structure-activity relationship studies. In total, 60 compounds were synthesized and tested against EV-D68 using the viral cytopathic effect assay. Three compounds 10a, 12a, and 12c were identified to have significantly improved potency (EC 50 < 1 μM) and a high selectivity index (>180) compared with dibucaine against five different strains of EV-D68 viruses. These compounds also showed potent antiviral activity in neuronal cells, such as A172 and SH-SY5Y cells, suggesting they might be further developed for the treatment of both respiratory infection as well as neuronal infection.",
author = "Rami Musharrafieh and Jiantao Zhang and Peter Tuohy and Naoya Kitamura and Bellampalli, {Shreya Sai} and Yanmei Hu and Rajesh Khanna and Jun Wang",
year = "2019",
month = "1",
day = "1",
doi = "10.1021/acs.jmedchem.9b00115",
language = "English (US)",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)

AU - Musharrafieh, Rami

AU - Zhang, Jiantao

AU - Tuohy, Peter

AU - Kitamura, Naoya

AU - Bellampalli, Shreya Sai

AU - Hu, Yanmei

AU - Khanna, Rajesh

AU - Wang, Jun

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Enterovirus D68 (EV-D68) is an atypical nonpolio enterovirus that mainly infects the respiratory system of humans, leading to moderate-to-severe respiratory diseases. In rare cases, EV-D68 can spread to the central nervous system and cause paralysis in infected patients, especially young children and immunocompromised individuals. There is currently no approved vaccine or antiviral available for the prevention and treatment of EV-D68. In this study, we aimed to improve the antiviral potency and selectivity of a previously reported EV-D68 inhibitor, dibucaine, through structure-activity relationship studies. In total, 60 compounds were synthesized and tested against EV-D68 using the viral cytopathic effect assay. Three compounds 10a, 12a, and 12c were identified to have significantly improved potency (EC 50 < 1 μM) and a high selectivity index (>180) compared with dibucaine against five different strains of EV-D68 viruses. These compounds also showed potent antiviral activity in neuronal cells, such as A172 and SH-SY5Y cells, suggesting they might be further developed for the treatment of both respiratory infection as well as neuronal infection.

AB - Enterovirus D68 (EV-D68) is an atypical nonpolio enterovirus that mainly infects the respiratory system of humans, leading to moderate-to-severe respiratory diseases. In rare cases, EV-D68 can spread to the central nervous system and cause paralysis in infected patients, especially young children and immunocompromised individuals. There is currently no approved vaccine or antiviral available for the prevention and treatment of EV-D68. In this study, we aimed to improve the antiviral potency and selectivity of a previously reported EV-D68 inhibitor, dibucaine, through structure-activity relationship studies. In total, 60 compounds were synthesized and tested against EV-D68 using the viral cytopathic effect assay. Three compounds 10a, 12a, and 12c were identified to have significantly improved potency (EC 50 < 1 μM) and a high selectivity index (>180) compared with dibucaine against five different strains of EV-D68 viruses. These compounds also showed potent antiviral activity in neuronal cells, such as A172 and SH-SY5Y cells, suggesting they might be further developed for the treatment of both respiratory infection as well as neuronal infection.

UR - http://www.scopus.com/inward/record.url?scp=85064334138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064334138&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.9b00115

DO - 10.1021/acs.jmedchem.9b00115

M3 - Article

C2 - 30912944

AN - SCOPUS:85064334138

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

ER -